At The Centre for In Vivo Modelling our scientists and clinical researchers use state-of-the-art in vivo models to address ...

Up to two in five advanced prostate cancer patients could be treated with a combination of two targeted drugs, according to new research. Findings by a team of scientists at The Institute of Cancer ...

Scientists have identified a more accurate way of predicting which patients with multiple myeloma, a type of blood cancer, are likely to relapse early following treatment. A study carried out by a ...

Suffering from psychological stress could further increase cancer risk in those already genetically predisposed to the disease, according to new research. The findings show that the stress hormone ...

Prostate cancer guidelines should change so that all men from the age of 40 with mutations in either the BRCA1 or BRCA2 gene are offered regular PSA testing to detect early signs of the disease, ...

The Oncogenetics group have three sub-groups working alongside each other: the lab group of scientists and clinical fellows, the data group of scientists and administrators and the clinical group of ...

Professor Eeles's goal is to develop new tests that could be used in prostate cancer screening, helping to identify men at a ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.